C0003153479P
This role leads Health Economics and Outcomes Research (HEOR) evidence strategies to support market access, reimbursement, and value demonstration for priority assets in Japan. The position serves as a trusted senior expert, providing decision-oriented recommendations to local and global stakeholders while shaping evidence generation plans across the product lifecycle. The role involves influencing cross-functional decisions and building external partnerships to advance evidence-based decision-making.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for C0003153479P.
C0003153479P didn’t post a salary, so this is our estimate from similar listings.
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Associate Director, HEOR Japan
Revolution Medicines
Executive Director, Health Economics & Outcomes Research (HEOR)
Travere Therapeutics
Director, HEOR/RWE Neurology Lead
Servier
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Director Global HEOR
Sobi